Samina Alam

Title: Samina Alam: Innovator in Oncolytic Virus Research

Introduction

Samina Alam is a prominent inventor based in Hershey, PA (US). She has made significant contributions to the field of cancer research through her innovative work with parvoviruses. With a total of 2 patents, her research focuses on developing methods and compositions for targeting neoplastic cells.

Latest Patents

Alam's latest patents include groundbreaking methods for utilizing parvoviruses, specifically the adeno-associated virus Type 2 (AAV2), as oncolytic agents. These inventions demonstrate the ability of AAV2 to selectively induce apoptosis in cancer cells while sparing healthy cells. The first patent outlines a method for killing cancer and other neoplastic cells by administering AAV2 proteins, such as Rep78 or Rep68, along with expression constructs or pharmaceutical compositions containing these proteins. The second patent further elaborates on the use of AAV2 virus, viral particles, or replication-incompetent vectors to target neoplastic cells effectively.

Career Highlights

Samina Alam is affiliated with the Penn State Research Foundation, where she continues her research in the field of oncolytic viruses. Her work has garnered attention for its potential to revolutionize cancer treatment by providing targeted therapies that minimize damage to healthy tissues.

Collaborations

Alam collaborates with Craig M Meyers, a fellow researcher, to advance their shared goals in cancer research. Their partnership enhances the scope and impact of their work in developing innovative therapeutic strategies.

Conclusion

Samina Alam's contributions to the field of cancer research through her patents on parvovirus methods highlight her role as an influential inventor. Her work promises to pave the way for more effective cancer treatments in the future.